Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

The deactivation of implantable cardioverter-defibrillators: medical, ethical, practical, and legal considerations.

Carlsson J, Paul NW, Dann M, Neuzner J, Pfeiffer D.

Dtsch Arztebl Int. 2012 Aug;109(33-34):535-41. doi: 10.3238/arztebl.2012.0535. Epub 2012 Aug 20. Review.

3.

Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.

Russo JE.

Am J Nurs. 2011 Oct;111(10):26-35. doi: 10.1097/01.NAJ.0000406411.49438.91. Review.

PMID:
21926561
4.

Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.

Kramer DB, Kesselheim AS, Salberg L, Brock DW, Maisel WH.

Am J Cardiol. 2011 Apr 1;107(7):1071-1075.e5. doi: 10.1016/j.amjcard.2010.11.036. Epub 2011 Feb 4.

5.

Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey.

Marinskis G, van Erven L; EHRA Scientific Initiatives Committee.

Europace. 2010 Aug;12(8):1176-7. doi: 10.1093/europace/euq272.

PMID:
20663788
6.

Ethical challenges of deactivation of cardiac devices in advanced heart failure.

Chamsi-Pasha H, Chamsi-Pasha MA, Albar MA.

Curr Heart Fail Rep. 2014 Jun;11(2):119-25. doi: 10.1007/s11897-014-0194-8. Review.

PMID:
24619521
7.

Deactivation of pacemakers and implantable cardioverter-defibrillators.

Kramer DB, Mitchell SL, Brock DW.

Prog Cardiovasc Dis. 2012 Nov-Dec;55(3):290-9. doi: 10.1016/j.pcad.2012.09.003. Review.

8.

[Implantable cardioverter-defibrillator deactivation at the end of life: ethical, clinical and communication issues].

RomanĂ² M, Piga MA, Bertona R, Negro R, Ruggeri C, Zorzoli F, Villani R.

G Ital Cardiol (Rome). 2017 Feb;18(2):139-149. doi: 10.1714/2663.27299. Review. Italian.

PMID:
28398367
9.

Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.

Kirkpatrick JN, Gottlieb M, Sehgal P, Patel R, Verdino RJ.

Am J Cardiol. 2012 Jan 1;109(1):91-4. doi: 10.1016/j.amjcard.2011.08.011. Epub 2011 Sep 22.

PMID:
21943937
10.

[Treating ICD patients at the end of their lives: attitudes, knowledge, and behavior of doctors and patients. A critical literature analysis].

Ladwig KH, Ischinger NF, Ronel J, Kolb C.

Herzschrittmacherther Elektrophysiol. 2011 Sep;22(3):151-6. doi: 10.1007/s00399-011-0138-x. Review. German.

PMID:
21769624
11.

Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes.

Mueller PS, Jenkins SM, Bramstedt KA, Hayes DL.

Pacing Clin Electrophysiol. 2008 May;31(5):560-8. doi: 10.1111/j.1540-8159.2008.01041.x.

PMID:
18439169
12.

[Deactivation of implantable defibrillators--also an ethical issue. Written routines of the process are necessary as illustrated by the described case report].

Carlsson J, Mansson A, Olsson D.

Lakartidningen. 2011 Mar 9-15;108(10):536-9. Swedish. No abstract available.

PMID:
21744554
13.

Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.

Kapa S, Mueller PS, Hayes DL, Asirvatham SJ.

Mayo Clin Proc. 2010 Nov;85(11):981-90. doi: 10.4065/mcp.2010.0431. Epub 2010 Sep 15.

14.

Within you/without you: biotechnology, ontology, and ethics.

Sulmasy DP.

J Gen Intern Med. 2008 Jan;23 Suppl 1:69-72. doi: 10.1007/s11606-007-0326-x. Review.

15.

Defibrillator patients should not be denied a peaceful death.

Westerdahl AK, Sutton R, Frykman V.

Int J Cardiol. 2015 Mar 1;182:440-6. doi: 10.1016/j.ijcard.2015.01.012. Epub 2015 Jan 6.

PMID:
25597981
16.

Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life.

Gura MT.

AACN Adv Crit Care. 2015 Oct-Dec;26(4):356-63. doi: 10.1097/NCI.0000000000000111. Review.

PMID:
26484996
17.

Ethical and legal perspective of implantable cardioverter defibrillator deactivation or implantable cardioverter defibrillator generator replacement in the elderly.

Wright GA, Klein GJ, Gula LJ.

Curr Opin Cardiol. 2013 Jan;28(1):43-9. doi: 10.1097/HCO.0b013e32835b0b3b. Review.

PMID:
23128499
18.

Deactivation of implantable cardioverter-defibrillators at end of life.

Pettit SJ, Jackson CE, Gardner RS.

Future Cardiol. 2013 Nov;9(6):885-96. doi: 10.2217/fca.13.81. Review.

PMID:
24180544
19.

Documented consent process for implantable cardioverter-defibrillators and implications for end-of-life care in older adults.

Niewald A, Broxterman J, Rosell T, Rigler S.

J Med Ethics. 2013 Feb;39(2):94-7. doi: 10.1136/medethics-2012-100613. Epub 2012 Nov 8.

PMID:
23139392
20.

EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy.

Padeletti L, Arnar DO, Boncinelli L, Brachman J, Camm JA, Daubert JC, Hassam SK, Deliens L, Glikson M, Hayes D, Israel C, Lampert R, Lobban T, Raatikainen P, Siegal G, Vardas P; Reviewers:, Kirchhof P, Becker R, Cosio F, Loh P, Cobbe S, Grace A, Morgan J; EuropeanHeart RhythmAssociation; Heart Rhythm Society.

Europace. 2010 Oct;12(10):1480-9. doi: 10.1093/europace/euq275. Epub 2010 Jul 30. Erratum in: Europace. 2011 Apr;13(4):599. Kassam, Sarah [corrected to Hassam, Sarah K].

PMID:
20675674

Supplemental Content

Support Center